Philadelphia Jury Returns $250,000 Verdict Against J&J in Latest Baby Powder-Ovarian Cancer Trial
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Business Wire
Outcome marks the first of several trials scheduled for 2026 PHILADELPHIA--(BUSINESS WIRE)--A jury in the Philadelphia Court of Common Pleas has found Johnson & Johnson (NYSE:JNJ) responsible for the company’s baby powder products contributing to the death of a Pennsylvania woman.The jury deliberated for more than three days before returning a verdict totaling $250,000 on behalf of the estate of York, Pennsylvania, resident Gayle Emerson, who died as a result of ovarian cancer in November of 2019 after filing her lawsuit six months earlier. The verdict included $50,000 in compensatory damages to Ms. Emerson’s family and $200,000 in punitive damages against the company on claims of product liability, failure to warn about the products’ dangers, and negligence.According to court testimony, Ms. Emerson used J&J’s talc-based body powders for feminine hygiene for more than 45 years and was diagnosed with ovarian cancer in 2015 at the age of 64.“It’s important to note that this jury foun
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial [Yahoo! Finance Canada]Yahoo! Finance Canada
- Pennsylvania jury finds Johnson & Johnson liable for cancer in latest talc trial [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson (JNJ) Reports 100% Success in OMNY-AF Study [Yahoo! Finance]Yahoo! Finance
- TrumpRx is here and it helps, though a bit less than advertised [Fortune]Fortune
- Is Johnson & Johnson a Buy, Sell, or Hold in 2026? [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 1/21/26 - Beat
JNJ
Sec Filings
- 2/13/26 - Form 13F-HR
- 2/13/26 - Form 144
- 2/11/26 - Form 4
- JNJ's page on the SEC website